ClinConnect ClinConnect Logo
Search / Trial NCT06328933

Intermittent Oral Tube on Feeding Amount

Launched by COPKA SONPASHAN · Mar 18, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating how two different methods of feeding can affect the nutritional intake of patients who have had an ischemic stroke, which is a type of stroke caused by a blockage in the blood supply to the brain. Participants will be randomly assigned to one of two groups: one group will receive nutrition through an Intermittent Oro-esophageal Tube, while the other group will use a Nasogastric Tube. Both groups will also receive standard rehabilitation treatment. The goal is to see if the method of feeding can improve the amount of food patients can take in and their overall nutritional health.

To be eligible for this trial, participants must be over 18 years old and diagnosed with ischemic stroke, along with having difficulty swallowing confirmed by a specific test. They should also be alert and stable, without a history of prior strokes. People with certain health conditions, such as severe liver or kidney problems, or those who are pregnant or nursing, will not be included in the study. If you decide to participate, you can expect to receive either of the two feeding methods and be monitored for changes in your nutritional status throughout the trial. This study aims to find better ways to support nutrition for stroke recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age\>18 years.
  • Meeting the diagnostic criteria for ischemic stroke .
  • Dysphagia confirmed by Videofluoroscopic Swallowing Study.
  • Clear consciousness.
  • No history of prior stroke.
  • Stable vital signs.
  • Exclusion Criteria:
  • Dysphagia that might be caused by other diseases that might cause dysphagia, such as head and neck tumors, traumatic brain injury, myasthenia gravis, etc.
  • Complicated with severe liver and kidney failure, tumors, or hematological disorders.
  • Simultaneously in need to undergo other therapy that might affect the outcomes of this study.
  • Pregnant or nursing females.

About Copka Sonpashan

Copka Sonpashan is a leading clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development. With a focus on enhancing patient care, the organization specializes in designing and executing clinical trials across various therapeutic areas, ensuring compliance with regulatory standards and ethical guidelines. By fostering collaboration with healthcare professionals and leveraging cutting-edge technologies, Copka Sonpashan aims to expedite the drug development process while maintaining a steadfast commitment to patient safety and scientific integrity.

Locations

Patients applied

0 patients applied

Trial Officials

Nieto Li

Study Chair

Site Coordinator of United Medical Group located in Miami

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported